An Analytical Approach to Assess the Predictive Value of Biomarkers in Phase II Decision Making

REFERENCES

• Berry , D. A. ( 2006 ). Bayesian clinical trials . Nature Reviews Drug Discovery 5 : 27 – 36 .
   PubMed Web of Science ®Google Scholar
• Brown , B. W. , Herson , J. , Atkinson , E. , Rozell , M. E. ( 1987 ). Projection from previous studies: A Bayesian and frequentist compromise . Controlled Clinical Trials 8 : 29 – 44 .
   PubMedGoogle Scholar
• Cox , D. R. , Hinkley , D. V. ( 2000 ). Theoretical Statistics . Boca Raton , FL : Chapman & Hall/CRC .
   Google Scholar
• Frangakis , C. E. , Rubin , D. B. ( 2002 ). Principal stratification in causal inference . Biometrics 58 : 21 – 29 .
   PubMed Web of Science ®Google Scholar
• Liu , F. ( 2010 ). An extension of Bayesian expected power and its application in decision making . Journal of Biopharmaceutical Statistics 20 ( 5 ) 941 – 953 .
   PubMed Web of Science ®Google Scholar
• Maurer , W. ( 2005 ). Creative and innovative statistics in clinical research and development . Methods of Information in Medicine 44 : 551 – 560 .
   PubMed Web of Science ®Google Scholar
• Orloff , J. , Douglas , F. , Pinheiro , J. , Levinson , S. , Branson , M. , Chaturvedi , P. , Ette , E. , Gallo , P. , Hirsch , G. , Mehta , C. , Patel , N. , Sabir , S. , Springs , S. , Stanski , D. , Evers , M. R. , Fleming , E. , Singh , N. , Tramontin , T. , Golub , H. ( 2009 ). The future of drug development: Advancing clinical trial design . Nature Reviews Drug Discovery 8 : 949 – 957 .
   PubMed Web of Science ®Google Scholar
• Rutherford , M. , Ramenghi , L. A. , Edwards , D. A. , Brocklehurst , P. , Halliday , H. , Levene , M. , Strohm , B. , Thoresen , M. , Whitelaw , A. , Azzopardi , D. ( 2010 ). Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: A nested substudy of a randomised controlled trial . Lancet Neurology 9 : 39 – 45 .
   PubMed Web of Science ®Google Scholar
• Stallard , N. , Whitehead , J. , Cleall , S. ( 2005 ). Decision-making in a phase II clinical trial: A new approach combining Bayesian and frequentist concepts . Pharmaceutical Statistics 4 : 119 – 128 .
   Web of Science ®Google Scholar
• Su , Z. ( 2010 ). Assessing the success probability of a phase III clinical trial based on phase II data . Contemporary Clinical Trials 31 : 620 – 623 .
   PubMed Web of Science ®Google Scholar
• Thoresen , M. , Hellstrom-Westas , L. , Liu , X. , de Vries , L. S. ( 2010 ). Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia . Pediatrics 126 : 131 – 139 .
   PubMed Web of Science ®Google Scholar
• Weir , C. J. , Walley , R. J. ( 2006 ). Statistical evaluation of biomarkers as surrogate endpoints: A literature review . Statistics in Medicine 25 : 183 – 203 .
   PubMed Web of Science ®Google Scholar
• Whitehead , J. ( 1997 ). The Design and Analysis of Sequential Clinical Trials . New York , NY : Wiley .
   Google Scholar